Swimming against the STREAM: Why STREAM 2 data cannot be easily applied to MDR-TB patients across India.

Swimming against the STREAM: Why STREAM 2 data cannot be easily applied to MDR-TB patients across India.
复制标题

DOI：
10.4103/lungindia.lungindia_74_23
复制
发表时间：
2023-05
期刊：
Lung India : official organ of Indian Chest Society
影响因子：
--
通讯作者：
Rodrigues C
Rodrigues C
中科院分区：
其他
文献类型：
--
作者：
Udwadia ZF;Patel JM;Batyala M;Tornheim JA;Rodrigues C
来源链接：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298808/

文献摘要

参考文献

相似文献

""
Bedaquiline Drug Resistance Emergence Assessment in Multidrug-Resistant Tuberculosis (MDR-TB): a 5-Year Prospective In Vitro Surveillance Study of Bedaquiline and Other Second-Line Drug Susceptibility Testing in MDR-TB Isolates.
DOI： 10.1128/jcm.02919-20
发表时间： 2022-01-19
期刊： Journal of clinical microbiology
影响因子： 9.4
作者：
Kaniga K;Hasan R;Jou R;Vasiliauskienė E;Chuchottaworn C;Ismail N;Metchock B;Miliauskas S;Viet Nhung N;Rodrigues C;Shin S;Simsek H;Smithtikarn S;Ngoc ALT;Boonyasopun J;Kazi M;Kim S;Kamolwat P;Musteikiene G;Sacopon CA;Tahseen S;Vasiliauskaitė L;Wu MH;Vally Omar S
通讯作者： Vally Omar S
Few eligible for the newly recommended short course MDR-TB regimen at a large Mumbai private clinic
DOI： 10.1186/s12879-019-3726-8
发表时间： 2019-01-28
期刊： BMC INFECTIOUS DISEASES
影响因子： 3.7
作者：
Udwadia, Zarir F.;Tornheim, Jeffrey A.;Gupta, Amita
通讯作者： Gupta, Amita
Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial.
DOI： 10.1016/s0140-6736(22)02078-5
发表时间： 2022-11-26
期刊： Lancet (London, England)
影响因子： --
作者：
Goodall RL;Meredith SK;Nunn AJ;Bayissa A;Bhatnagar AK;Bronson G;Chiang CY;Conradie F;Gurumurthy M;Kirenga B;Kiria N;Meressa D;Moodliar R;Narendran G;Ngubane N;Rassool M;Sanders K;Solanki R;Squire SB;Torrea G;Tsogt B;Tudor E;Van Deun A;Rusen ID;STREAM study collaborators
通讯作者： STREAM study collaborators